Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Table 9

The relationship between mGPS and PS and 3-month survival rate (%, SE) in patients with TNM stage IIIb/IV NSCLC (𝑛=374).

PS	mGPS			Total number of patients
	0	1	2
0	100% (0)	92% (8)	100% (0)	28
1	94% (4)	73% (6)	55% (9)	119
2	65% (11)	62% (7)	43% (8)	105
3	NC	29% (11)	23% (8)	55
4	NC	NC	NC	7
Total number of patients	61	134	111	—

NC: not calculated where 𝑁<10.